Search results for "Highlights"
Patients with late-onset type 1 diabetes commonly treated as having type 2 diabetes
An analysis of patients with insulin-treated diabetes found that 38% of those with late-onset type 1 diabetes did not receive insulin at diagnosis, nearly half of whom reported a type 2 diabetes diagnosis.
https://diabetes.acponline.org/archives/2019/05/10/3.htm
10 May 2019
Lowering serum urate levels with allopurinol did not improve kidney outcomes in patients with type 1 diabetes
Randomized trial participants with type 1 diabetes and mild-to-moderate diabetic kidney disease who received allopurinol or placebo had similar estimated glomerular filtration rates after three years.
https://diabetes.acponline.org/archives/2020/07/10/1.htm
10 Jul 2020
Patient-centered diabetes care varies in intensity by both disease- and patient-related factors
Patients were more likely to choose more intensive care after an annual consultation if they had a high level of education, if they were concerned about illness, if they had set goals for their care, and if they had comorbid conditions.
https://diabetes.acponline.org/archives/2019/07/12/3.htm
12 Jul 2019
Metformin associated with more long-term weight loss than lifestyle change in prediabetes patients
Other independent predictors of long-term weight loss included greater weight loss in the first year and older age, according to this follow-up analysis of the Diabetes Prevention Program.
https://diabetes.acponline.org/archives/2019/05/10/2.htm
10 May 2019
Weight loss through gastric bypass or diet improved insulin sensitivity in patients with type 2 diabetes
Results from this small study suggest that reducing adipose tissue volume, by whatever means, will improve blood glucose control in patients with type 2 diabetes, an accompanying editorial noted.
https://diabetes.acponline.org/archives/2020/09/11/1.htm
11 Sep 2020
Cardiology guidance supports use of SGLT-2 inhibitors, GLP-1 receptor agonists for CV benefits in diabetes
Evidence on sodium-glucose cotransporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists indicates that these drugs can be used not just for glucose control but for cardiovascular (CV) risk reduction in patients with type 2 diabetes, according to a new expert pathway.
https://diabetes.acponline.org/archives/2020/08/14/1.htm
14 Aug 2020
ADA updates standards of care related to CV, renal health in type 2 diabetes
The updates were based on findings from the industry-funded CREDENCE (Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy) trial.
https://diabetes.acponline.org/archives/2019/06/14/2.htm
14 Jun 2019
Insulin initiation in the hospital associated with death, ED visits, readmissions in older patients
The study authors noted that older patients who begin insulin therapy while hospitalized are a vulnerable population for whom additional resources are needed during the transition to outpatient care.
https://diabetes.acponline.org/archives/2019/03/08/2.htm
8 Mar 2019
Drug-eluting stents may not confer advantage in diabetic patients
An editorial noted that drug-eluting stents may work for noncomplex lesions in patients with diabetes, but complex disease states incurred high rates of myocardial infarction and revascularization.
https://diabetes.acponline.org/archives/2019/01/11/3.htm
11 Jan 2019
Early subspecialist involvement led to reduced infections among inpatients with diabetes
Researchers studied an early intervention model in which an inpatient diabetes team electronically identified patients with hyperglycemia and aimed to provide bedside management within 24 hours of admission, compared with a referral-based consultation service.
https://diabetes.acponline.org/archives/2019/04/05/3.htm
5 Apr 2019